Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Carroll

Showing results (521-530 of 573) with videos related to

Pageof 58
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 3, 2016
Resurgence of Ebola Virus Disease in Guinea Linked to a Survivor With Virus Persistence in Seminal Fluid for More Than 500 DaysBoubacar Diallo, Daouda Sissoko, Nicholas J Loman, et al.
Lancet (London, England)|December 27, 2016
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)Ana Maria Henao-Restrepo, Anton Camacho, Ira M Longini, et al.
The American Journal of Gastroenterology|September 7, 2017
Corrigendum: Rural and Urban Residence During Early Life Is Associated with a Lower Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort StudyEric I Benchimol, Gilaad G Kaplan, Anthony R Otley, et al.
Nature Communications|September 23, 2021
A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19Jiandong Huo, Halina Mikolajek, Audrey Le Bas, et al.
The American Journal of Gastroenterology|July 26, 2017
Rural and Urban Residence During Early Life is Associated with Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort StudyEric I Benchimol, Gilaad G Kaplan, Anthony R Otley, et al.
Nature Communications|August 18, 2021
Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concernDonal T Skelly, Adam C Harding, Javier Gilbert-Jaramillo, et al.
Gastroenterology|October 2, 2022
Unfermented β-fructan Fibers Fuel Inflammation in Select Inflammatory Bowel Disease PatientsHeather K Armstrong, Michael Bording-Jorgensen, Deanna M Santer, et al.
Clinical and Experimental Immunology|April 20, 2024
Obesity differs from diabetes mellitus in antibody and T-cell responses post-COVID-19 recoveryMohammad Ali, Stephanie Longet, Isabel Neale, et al.
Journal of the Canadian Association of Gastroenterology|September 7, 2023
The 2023 Impact of Inflammatory Bowel Disease in Canada: Special Populations-Children and Adolescents with IBDWael El-Matary, Matthew W Carroll, Colette Deslandres, et al.
Clinical Epidemiology|December 7, 2018
Rural and urban disparities in the care of Canadian patients with inflammatory bowel disease: a population-based studyEric I Benchimol, M Ellen Kuenzig, Charles N Bernstein, et al.
Pageof 58

Showing results (521-530 of 573) with videos related to

Sort By:
Pageof 58
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 3, 2016
Resurgence of Ebola Virus Disease in Guinea Linked to a Survivor With Virus Persistence in Seminal Fluid for More Than 500 DaysBoubacar Diallo, Daouda Sissoko, Nicholas J Loman, et al.
Lancet (London, England)|December 27, 2016
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)Ana Maria Henao-Restrepo, Anton Camacho, Ira M Longini, et al.
The American Journal of Gastroenterology|September 7, 2017
Corrigendum: Rural and Urban Residence During Early Life Is Associated with a Lower Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort StudyEric I Benchimol, Gilaad G Kaplan, Anthony R Otley, et al.
Nature Communications|September 23, 2021
A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19Jiandong Huo, Halina Mikolajek, Audrey Le Bas, et al.
The American Journal of Gastroenterology|July 26, 2017
Rural and Urban Residence During Early Life is Associated with Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort StudyEric I Benchimol, Gilaad G Kaplan, Anthony R Otley, et al.
Nature Communications|August 18, 2021
Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concernDonal T Skelly, Adam C Harding, Javier Gilbert-Jaramillo, et al.
Gastroenterology|October 2, 2022
Unfermented β-fructan Fibers Fuel Inflammation in Select Inflammatory Bowel Disease PatientsHeather K Armstrong, Michael Bording-Jorgensen, Deanna M Santer, et al.
Clinical and Experimental Immunology|April 20, 2024
Obesity differs from diabetes mellitus in antibody and T-cell responses post-COVID-19 recoveryMohammad Ali, Stephanie Longet, Isabel Neale, et al.
Journal of the Canadian Association of Gastroenterology|September 7, 2023
The 2023 Impact of Inflammatory Bowel Disease in Canada: Special Populations-Children and Adolescents with IBDWael El-Matary, Matthew W Carroll, Colette Deslandres, et al.
Clinical Epidemiology|December 7, 2018
Rural and urban disparities in the care of Canadian patients with inflammatory bowel disease: a population-based studyEric I Benchimol, M Ellen Kuenzig, Charles N Bernstein, et al.
Pageof 58